Current approved therapeutic strategies for IPF and LC treatment

Discovery of Novel Selective and Orally Bioavailable Phosphodiesterase-1 Inhibitors for the Efficient Treatment of Idiopathic Pulmonary Fibrosis

Comparison of survival probabilities of IPF patients with and without

Dario Andrisani's research works

Enrico CLINI, Professor in Respiratory Medicine

PDF) Molecular Mechanisms and Cellular Contribution from Lung

IJMS, Free Full-Text

Traditional Chinese medicine inspired dual-drugs loaded inhalable nano-therapeutics alleviated idiopathic pulmonary fibrosis by targeting early inflammation and late fibrosis, Journal of Nanobiotechnology

Stem Cell Therapy for Aphasia - A New Approach

Giorgia GUAITOLI, Resident